BACKGROUND: Recurrent inflammation in chronic pancreatitis (CP) is not well understood. AIMS: To investigate whether decorin, an extracellular matrix (ECM) proteoglycan with macrophage modulating activity, is a pathogenic factor allowing diseased pancreatic stroma to sustain inflammation by affecting the cytokine profile of accumulating inflammatory cells. METHODS: Decorin was examined in 18 donors and 32 patients with CP by quantitative reverse transcription polymerase chain reaction (QRT-PCR), western blotting, and immunohistochemistry of pancreatic specimens. QRT-PCR was used to assess cytokine expression in donor peripheral blood mononuclear cells (PBMC), exposed or not to decorin in vitro, and to compare it with the cytokine profile of circulating and resident mononuclear cells (MNC) of patients with CP. RESULTS: In CP, desmoplasia is associated with overexpression of decorin in the growing ECM and enlarged pancreatic nerves. In culture, exposure of MNC to decorin stimulated expression of the MNC recruiting chemokine MCP-1. In biopsies, MNC infiltrates in decorin rich CP tissue showed a 300-fold upregulation of MCP-1 compared with decorin free peripheral blood, whereas no difference was found in basal MCP-1 expression in PBMC of patients versus donors. This effect was specific for MCP1-other inflammatory cytokines, such as interleukin 1beta and tumour necrosis factor alpha, were not affected. CONCLUSION: Decorin is a molecular marker of desmoplasia in CP, and excessive decorin may allow fibrotic masses to nourish and protract inflammation by deregulating the process of MNC accumulation and activation. These data provide a molecular basis for surgical resection of diseased tissue as a treatment option in CP.
BACKGROUND: Recurrent inflammation in chronic pancreatitis (CP) is not well understood. AIMS: To investigate whether decorin, an extracellular matrix (ECM) proteoglycan with macrophage modulating activity, is a pathogenic factor allowing diseased pancreatic stroma to sustain inflammation by affecting the cytokine profile of accumulating inflammatory cells. METHODS: Decorin was examined in 18 donors and 32 patients with CP by quantitative reverse transcription polymerase chain reaction (QRT-PCR), western blotting, and immunohistochemistry of pancreatic specimens. QRT-PCR was used to assess cytokine expression in donor peripheral blood mononuclear cells (PBMC), exposed or not to decorin in vitro, and to compare it with the cytokine profile of circulating and resident mononuclear cells (MNC) of patients with CP. RESULTS: In CP, desmoplasia is associated with overexpression of decorin in the growing ECM and enlarged pancreatic nerves. In culture, exposure of MNC to decorin stimulated expression of the MNC recruiting chemokine MCP-1. In biopsies, MNC infiltrates in decorin rich CP tissue showed a 300-fold upregulation of MCP-1 compared with decorin free peripheral blood, whereas no difference was found in basal MCP-1 expression in PBMC of patients versus donors. This effect was specific for MCP1-other inflammatory cytokines, such as interleukin 1beta and tumour necrosis factor alpha, were not affected. CONCLUSION: Decorin is a molecular marker of desmoplasia in CP, and excessive decorin may allow fibrotic masses to nourish and protract inflammation by deregulating the process of MNC accumulation and activation. These data provide a molecular basis for surgical resection of diseased tissue as a treatment option in CP.
Authors: A C Bateman; S M Turner; K S A Thomas; P R McCrudden; D R Fine; P A Johnson; C D Johnson; J P Iredale Journal: Gut Date: 2002-04 Impact factor: 23.059
Authors: N Nakamura; D A Hart; R S Boorman; Y Kaneda; N G Shrive; L L Marchuk; K Shino; T Ochi; C B Frank Journal: J Orthop Res Date: 2000-07 Impact factor: 3.494
Authors: J Dudás; I Kovalszky; M Gallai; J O Nagy; Z Schaff; T Knittel; M Mehde; K Neubauer; F Szalay; G Ramadori Journal: Am J Clin Pathol Date: 2001-05 Impact factor: 2.493
Authors: Mark Hartel; Adrien A Tempia-Caliera; Moritz N Wente; Kaspar Z'graggen; Helmut Friess; Markus W Büchler Journal: Langenbecks Arch Surg Date: 2003-03-18 Impact factor: 3.445
Authors: S V Shrikhande; M E Martignoni; M Shrikhande; A Kappeler; H Ramesh; A Zimmermann; M W Büchler; H Friess Journal: Br J Surg Date: 2003-12 Impact factor: 6.939
Authors: Vitor H Pomin; Younghee Park; Rongrong Huang; Christian Heiss; Joshua S Sharp; Parastoo Azadi; James H Prestegard Journal: Glycobiology Date: 2012-02-17 Impact factor: 4.313
Authors: Rosetta Merline; Kristin Moreth; Janet Beckmann; Madalina V Nastase; Jinyang Zeng-Brouwers; José Guilherme Tralhão; Patricia Lemarchand; Josef Pfeilschifter; Roland M Schaefer; Renato V Iozzo; Liliana Schaefer Journal: Sci Signal Date: 2011-11-15 Impact factor: 8.192
Authors: Wenrui Hao; Hannah M Komar; Phil A Hart; Darwin L Conwell; Gregory B Lesinski; Avner Friedman Journal: Proc Natl Acad Sci U S A Date: 2017-04-24 Impact factor: 11.205